Eli Lilly also responded to the President's tariff warnings by investing $27 billion to construct four manufacturing ...

Pfizer CEO Bourla says company can shift operations from foreign sites to US manufacturing network to counter Trump's tariffs ...

Pfizer CEO Albert Bourla on Monday said that the company might move overseas manufacturing to its existing plants in the ...

Europe’s pharmaceutical firms are rushing to prepare for the potential fallout of U.S. import duties, even as analysts warn ...

"I was expecting him probably to win. It was very big win," Pfizer's CEO Albert Bourla said of President Donald Trump's ...

Big Pharma executives feel optimistic about their industry’s trajectory under a second Donald Trump presidency, with regulation rollbacks and other changes likely to boost bottom lines for drugmakers, ...

As biopharma players continue to parse out what the second Trump administration means for the industry, Pfizer CEO Albert ...

Pfizer CEO Albert Bourla said on Monday the drugmaker might move overseas manufacturing to its existing plants in the United ...

TD Cowen 45th Annual Health Care Conference March 3, 2025 10:30 AM ETCompany ParticipantsAlbert Bourla - Chairman and ...

(Reuters) -Pfizer CEO Albert Bourla said on Monday the drugmaker might move overseas manufacturing to its existing plants in ...

Pfizer CEO Albert Bourla announced the possibility of shifting overseas manufacturing to U.S. plants. This response is due to ...